Ying Cheng, Liqin Lu, Wu Zhuang, Dongyuan Zhu, Yanqiu Zhao, Na Li, Yubiao Guo, Zhouguang Hui, Yan Li, Ziping Wang, Peng Zhang, Yan Wang. "First report of efficacy and safety results from a phase 2 trial evaluating BNT327/PM8002 plus chemotherapy (chemo) as first-line treatment (1L) in unresectable malignant mesothelioma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8511